PriceTargets.com logo

OTCMKTS:CLSH - CLS Holdings USA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.10
  • Forecasted Upside: -54.57 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.22 As of 02/26/2021 09:28 PM ET
▼ -0.0049 (-2.18%)
1 month | 3 months | 12 months
Get New CLS Holdings USA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLSH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLSH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.10
▼ -54.57% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for CLS Holdings USA in the last 3 months. The average price target is $0.10, with a high forecast of $0.10 and a low forecast of $0.10. The average price target represents a -54.57% upside from the last price of $0.22.
Buy
The current consensus among 2 contributing investment analysts is to buy stock in CLS Holdings USA. This rating has held steady since August 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/7/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
8/3/2020Panmure GordonInitiated CoverageBuy
i
4/28/2020Canaccord GenuityDowngradeBuy ➝ Hold$0.10
i
2/22/2019Canaccord GenuityInitiated CoverageBuy
i
(Data available from 3/1/2016 forward)
CLS Holdings USA logo
CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Miami, Florida.
Read More

Today's Range

Now: $0.22
$0.20
$0.27

50 Day Range

MA: $0.21
$0.14
$0.35

52 Week Range

Now: $0.22
$0.04
$0.39

Volume

226,800 shs

Average Volume

307,503 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CLS Holdings USA?

The following Wall Street analysts have issued reports on CLS Holdings USA in the last year: Canaccord Genuity, and Panmure Gordon.
View the latest analyst ratings for CLSH.

What is the current price target for CLS Holdings USA?

1 Wall Street analysts have set twelve-month price targets for CLS Holdings USA in the last year. Their average twelve-month price target is $0.10, suggesting a possible downside of 54.6%. Canaccord Genuity has the highest price target set, predicting CLSH will reach $0.10 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of $0.10 for CLS Holdings USA in the next year.
View the latest price targets for CLSH.

What is the current consensus analyst rating for CLS Holdings USA?

CLS Holdings USA currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLSH will outperform the market and that investors should add to their positions of CLS Holdings USA.
View the latest ratings for CLSH.

What other companies compete with CLS Holdings USA?

Other companies that are similar to CLS Holdings USA include (THCX.V), 31444, 438280, 815446, Abacus Health Products, Acreage, Althea Group, Applied Biosciences, AusCann Group, Ayr Strategies, Bio-Rad Laboratories, Blueberries Medical, Can B, Cannara Biotech and CannPal Animal Therapeutics.

How do I contact CLS Holdings USA's investor relations team?

The company's listed phone number is 888-438-9132. The official website for CLS Holdings USA is www.clsholdingsinc.com.